pharmacie et médicaments – Suspension de la réduction du plafond des remises sur les génériques

This written question asks about the suspension of a reduction in the rebate cap for generic medicines. It seeks clarification on the potential impact of this policy on the pharmaceutical market and access to medicines. The question concerns pharmaceutical companies, healthcare providers, and patients who rely on generic medications. It aims to understand the implications for drug pricing and availability.